Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger (SDGR – Research Report) today. The company’s shares closed last Friday at $22.64. See what stocks are receiving strong ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback